illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Elanco
Company logo

Elanco | Sustainability Performance

https://www.elanco.com

Develops and markets products for animal health, offering solutions for disease prevention, treatment, and performance enhancement. Serves livestock and pet markets with a focus on innovation and sustainability.

1954

United States

5,001 - 10,000 employees

Veterinary

$1B - 10B in revenue

N/A in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#4689
Overallⓘ
#883
in United Statesⓘ
#4
in Veterinaryⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

3 out of 6

Overview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater Management
Governance
Targets
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
CVS Group

United Kingdom, Health Care, Veterinary


Company logo
Vimian

Sweden, Health Care, Veterinary


Company logo
Animalcare Group

United Kingdom, Health Care, Veterinary

CO2 scope 1 + 2 ⓘDirect emissions from owned or controlled sources, combined with indirect emissions from purchased electricity calculated using grid-average emission factors based on where the energy is consumed.
332.3KCO2e tonnes, 2024
Critical
Waste generated ⓘTotal waste generated through the company's direct operations, including both hazardous and non-hazardous materials.
114.1Ktonnes, 2024
Critical
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
11.6B$, 2026▼42.3% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
4.4B$, 2024▼0.5% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
7.75%2024

Intensity


Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark

70.4

B/M 70.4

175.6

B/M 175.6

260.6

B/M 260.6

24.2

B/M 24.2


Powered by illuminem and GIST Impact

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Elanco Animal Health Incorporated, US major animal health (Eli Lilly spinoff 2018, Bayer Animal Health acquisition 2020 USD 7.6 billion), has faced sustained class actions over the contested 2020 USD 7.6 billion Bayer Animal Health acquisition integration challenges with subsequent sustained share price collapse and disclosed material customer concentration affecting US institutional shareholders amid global animal health customer demand normalization pressure.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

11+

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.


    Available in
    Scale package

    Access
  • Email

  • Email